Timothy P. Noyes, CHIEF EXECUTIVE OFFICER at Aerovate Therapeutics, Inc. (AVTE), sold 29,194 shares at $27.90 ($789K) on 2023-01-03, disclosed to the SEC on 2023-01-05.
Open-market sale of $789k AVTE by CHIEF EXECUTIVE OFFICER. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Something here stands out, but not much.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $26.80 | 11,927 | $320K | 40.5% |
| 2 | $26.80 | 11,927 | $320K | 40.5% |
| 3 | $27.90 | 2,267 | $63K | 8.0% |
| 4 | $27.90 | 2,267 | $63K | 8.0% |
| 5 | $28.78 | 791 | $23K | 2.9% |
| 6 | $29.82 | 15 |
| $447 |
| 0.1% |
| Total | $27.03 avg | 29,194 | $789K | 100% |
| Filing → |
| AVTE | SELL | 2024-04-18 | $494K | — | Filing → |
| AVTE | SELL | 2024-04-03 | $519K | — | Filing → |
| AVTE | SELL | 2023-11-03 | $11K | — | Filing → |